Cardiovascular and renal benefit of sodium-glucose co-transporter type 2 inhibitors in patients with Type 2 Diabetes. Man Lam SH, Alam U, Lip GYH. Am J Cardiol 2024 May 9:S0002-9149(24)00340.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Man Lam SH, Alam U, Lip GYH. Cardiovascular and renal benefit of sodium-glucose co-transporter type 2 inhibitors in patients with Type 2 Diabetes. Am J Cardiol 2024 May 9:S0002-9149(24)00340.
PMID: 38734398